Manufacturing challenges in regenerative medicine

Science Translational Medicine

Volumn 6, Issue 232, 2014, Pages

  Martin, Ivan ^a,b   Simmons, Paul J ^c   Williams, David F ^d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Mesoblast Limited   (Australia)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

BIOREACTOR; BIOTECHNOLOGICAL PRODUCTION; CELL ENGINEERING; CELL THERAPY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; CULTURE MEDIUM; FUNDING; HEALTH CARE COST; PRIORITY JOURNAL; PROCESS DESIGN; QUALITY CONTROL; REGENERATIVE MEDICINE; REIMBURSEMENT; SHORT SURVEY; STANDARDIZATION; TISSUE ENGINEERING; BIOLOGICAL THERAPY; HUMAN; PROCEDURES;

CELL- AND TISSUE-BASED THERAPY; HUMANS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84899126240     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008558     Document Type: Short Survey

References (7)

1. I. Martin, H. Baldomero, C. Bocelli-Tyndall, M. Y. Emmert, S. P. Hoerstrup, H. Ireland, J. Passweg, A. Tyndall, The survey on cellular and engineered tissue therapies in Europe in 2011. Tissue Eng. Part A. 20, 842-853 (2014).
2. I. Martin, T. Smith, D. Wendt, Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends Biotechnol. 27, 495-502 (2009).
3. A. Scherberich, R. Galli, C. Jaquiery, J. Farhadi, I. Martin, Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells 25, 1823-1829 (2007).
4. D. B. Kolesky, R. L. Truby, A. S. Gladman, T. A. Busbee, K. A. Homan, J. A. Lewis, 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv. Mater. 10.1002/adma.201305506 (2014).
5. P. Rama, S. Matuska, G. Paganoni, A. Spinelli, M. De Luca, G. Pellegrini, Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363, 147-155 (2010).
6. R. Verbeek, Generation of mesenchymal stem cells as a medicinal product in organ transplantation. Curr. Opin. Organ Transplant. 18, 65-70 (2013).
7. J. J. Rice, M. M. Martino, L. De Laporte, F. Tortelli, P. S. Briquez, J. A. Hubbell, Engineering the regenerative microenvironment with biomaterials. Adv. Healthc. Mater. 2, 57-71 (2013).